| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |